Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Zhangzhou Pientzehuang Pharmaceutical., Ltd    600436   CNE000001F21

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

(600436)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Zhangzhou Pientzehuang Pharmaceuticl Ltd : annual earnings release

04/11/2018 | 09:15am EST

The company will report its earnings for FY 2017 on 04/16/2018. Generally, the company reports earnings worse than estimates. In recent months, the 4 analysts from Thomson Reuters consensus have revised their EPS estimates upward.


© MarketScreener.com 2018
Stocks mentioned in the article
ChangeLast1st jan.
THOMSON REUTERS CORPORATION -0.58% 103.43 Delayed Quote.11.99%
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD -0.87% 210.38 End-of-day quote.91.48%
All news about ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
09/03China stocks end lower as high-flying consumer shares retreat
RE
2018LONDON STOCK EXCHANGE : Exclusive - FTSE Russell may give mainland China stocks ..
RE
2018MSCI lists 234 Chinese stocks for index inclusion in boost to capital markets
RE
2018ZHANGZHOU PIENTZEHUANG PHARMACEUTICL : annual earnings release
More news
Financials
Sales 2020 6 788 M 1 033 M 1 033 M
Net income 2020 1 661 M 253 M 253 M
Net cash 2020 5 690 M 865 M 865 M
P/E ratio 2020 77,1x
Yield 2020 0,39%
Capitalization 128 B 19 473 M 19 476 M
EV / Sales 2020 18,0x
EV / Sales 2021 14,7x
Nbr of Employees 2 371
Free-Float 35,3%
Chart ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Duration : Period :
Zhangzhou Pientzehuang Pharmaceutical., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 243,30 CNY
Last Close Price 212,23 CNY
Spread / Highest target 67,5%
Spread / Average Target 14,6%
Spread / Lowest Target -34,3%
EPS Revisions
Managers
NameTitle
Jian Shun Liu Chairman & General Manager
Wei Cheng Zhang Chairman-Supervisory Board
Dong Ming Hong Chairman-Supervisory Board
Fei Hong Chief Engineer
Ji Peng Chen Secretary, Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD93.16%19 473
MERCK KGAA22.64%67 521
KYOWA KIRIN CO., LTD.9.13%14 477
BETTA PHARMACEUTICALS CO., LTD.38.66%5 960
YUHAN CORPORATION35.94%3 707
RECIPHARM AB (PUBL)19.76%1 849